Your SlideShare is downloading. ×
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply



Published on

Published in: Technology

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Autoimmunity Autoimmunity • Immune recognition and injury of self tissues (autoimmunity) results from a loss of self tolerance. K.J.Goodrum 2006 Self Tolerance Peripheral T cell Tolerance Mechanisms • Tolerance to self is acquired by clonal • Immunological Ignorance: Very few self deletion or inactivation of developing proteins contain peptides that are presented lymphocytes. by a given MHC molecule at a level – Clonal deletion by ubiquitous self antigens sufficient for T cell activation,. Autoreactive T cells are present but not – Clonal inactivation by tissue-specific normally activated. antigens presented in the absence of co- stimulatory signals • Suppressor or regulatory T cells: mediate active suppression of autoreactive cells 1
  • 2. Peripheral T cell Tolerance Peripheral B cell Tolerance Mechanisms Mechanisms • Contact with soluble antigens: • Immunologically privileged sites: no lymphatic drainage or non-vascularized – downregulation of surface IgM, areas; presence of immunosuppressive inhibition of signaling anergic factors & FasL cells – Fas-mediated apoptosis of anergic B cell following secondary encounter with CD4 T cell Peripheral B cell Tolerance Mechanisms Peripheral B cell Tolerance Mechanisms • Contact with soluble antigens • Lack of T helper cell signals: – Apoptosis of autoreactive B cells – anergy generated by somatic hypermutation in – inhibited migration into follicles & germinal centers apoptosis in T cell areas of lymph tissue 2
  • 3. Loss of Self Tolerance • Most self peptides are presented at levels too low to engage effector T cells whereas those presented at high levels induce clonal deletion or anergy. • Autoimmunity arises most frequently to Tissue-specific antigens with only certain MHC molecules that present the peptide at an intermediate level recognized by T cells without inducing tolerance. MHC Association with Autoimmune Disease Fig. 13.33 • The level of autoantigenic peptide presented is determined by polymorphic residues in MHC molecules that govern the affinity of peptide binding. • Autoimmune diseases are associated with particular MHC genotypes. 3
  • 4. MHC Association with Autoimmune Disease • Only a few peptides can act as Fig. 13.4 autoantigens so there are a relatively few autoimmune syndromes. Type I Diabetes association with • Individuals with a particular HLA genotype autoimmune disease tend to recognize the same antigens with the same MHC. Mechanisms for Activation of Mechanisms for Activation of Autoreactive Lymphocytes Autoreactive Lymphocytes • Infectious triggers: • Infectious triggers: – stimulation of co-stimulatory signals, – Superantigen activity/polyclonal inappropriate MHC II expression, or cytokines activation – Molecular mimicry (cross-reaction) – Release of sequestered antigens – T cell bypass (pathogen binding to self protein/provision of carrier T cell epitope) 4
  • 5. Infectious Mechanisms that Break Self-Tolerance Fig. 13.42 Fig. 13.1 Organ-specific Autoimmune diseases • Antigens and autoimmunity restricted to specific organs in the body – Type I diabetes – Goodpasture’s syndrome – Multiple sclerosis – Grave’s disease – Hashimoto’ thyroiditis – Myasthenia gravis 5
  • 6. Systemic Autoimmune Disease • Antigens and autoimmunity are distributed in many tissues (systemic) – Rheumatoid arthritis – Systemic lupus erythematosus – Scleroderma – Primary Sjogrens’s syndrome – polymyositis 6
  • 7. Determinant spreading 7